I-Mab Announces New CFO
Ticker: NBP · Form: 6-K · Filed: Jul 15, 2024 · CIK: 1778016
Sentiment: neutral
Topics: leadership-change, cfo-appointment
Related Tickers: IMAB
TL;DR
I-Mab names new CFO, Joseph Skelton, effective July 15, 2024.
AI Summary
I-Mab announced leadership transitions on July 15, 2024. Joseph Skelton has been appointed as the Chief Financial Officer. The company is a biopharmaceutical company focused on developing and commercializing innovative biologics for the treatment of cancer and autoimmune diseases.
Why It Matters
A change in Chief Financial Officer can signal shifts in financial strategy or operational focus for the company.
Risk Assessment
Risk Level: low — This filing is a routine announcement of a leadership change and does not contain significant financial or operational disclosures that would inherently increase risk.
Key Players & Entities
- I-Mab (company) — Registrant
- Joseph Skelton (person) — Chief Financial Officer
- NASDAQ: IMAB (company) — Company Stock Ticker
FAQ
What is the date of the leadership transition announcement?
The announcement was made on July 15, 2024.
Who has been appointed as the new Chief Financial Officer?
Joseph Skelton has been appointed as the new Chief Financial Officer.
What is the company's stock ticker symbol?
The company's stock ticker symbol is IMAB.
What is the principal executive office address of I-Mab?
The principal executive office is located at 2440 Research Blvd, Suite 400, Rockville, MD 20850.
What type of report is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Filing Stats: 145 words · 1 min read · ~1 pages · Grade level 12.1 · Accepted 2024-07-15 07:45:14
Filing Documents
- tm2419452d1_6k.htm (6-K) — 9KB
- tm2419452d1_ex99-1.htm (EX-99.1) — 11KB
- tm2419452d1_ex99-1img001.jpg (GRAPHIC) — 4KB
- 0001104659-24-079691.txt ( ) — 26KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the Month of July, 2024 Commission File Number: 001-39173 I-MAB (Translation of registrant’s name into English) 2440 Research Blvd, Suite 400 Rockville, MD 20850 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press Release of I-Mab, dated July 15, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 15, 2024 I-MAB By: /s/ Joseph Skelton Name: Joseph Skelton Title: Chief Financial Officer